According to a new analysis from Future Market Insights, the potassium formate market is on a steady upward trajectory, projected to cross USD 950 million by 2033, with a consistent CAGR of 4.5% over ...

Sure, you can always reach for a glass of water — but plain H20 isn’t the most hydrating beverage around, according to a ...

Demand for potassium sorbate is on track to experience a steady rise, with its industry value estimated to reach USD 69.8 ...

About Xywav ® (calcium, magnesium, potassium, and sodium oxybates) oral solution Xywav is the only low-sodium oxybate approved by the U.S. Food and Drug Administration (FDA) ...

Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025 ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced late-breaking Phase 4 data evaluating treatment benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solution in ...

Sodium sulfate, potassium sulfate and magnesium sulfate oral solution 17.5 g/3.13g/1.6g are available in a cartons of two 6-oz. bottles. Related Topics PHARMACY ...

About Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solutionXywav is the only low-sodium oxybate approved by the U.S. Food and Drug Administration (FDA) for the treatment of ...

Morningstar brands and products Company Portfolio ...

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- – SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing ...

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was ...

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. ... Integra Pharma Solutions, LLC, is a licensed ...